Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

Michael O'Riordan

August 22, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Daily News

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

Todd Neale

January 30, 2019

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Caitlin E. Cox

January 04, 2019

Advertisement

Routine Anticoagulation Seems Warranted After TMVR: Review

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Aborted TAVR Procedures Are Waning in the US

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content